QCMC
TEVA icon

Quantum Capital Management (California)’s Teva Pharmaceuticals TEVA Stock Holding History

Quantum Capital Management (California)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$0 Hold
50
– – ﹤0.01% 282
2020
Q2 		$1K Hold
50
– – ﹤0.01% 303
2020
Q1 		$0 Hold
50
– – ﹤0.01% 320
2019
Q4 		$0 Hold
50
– – ﹤0.01% 327
2019
Q3 		$0 Buy
+50
New +$383 ﹤0.01% 332
2013
Q4 		– Sell
-150
Closed -$6K – 229
2013
Q3 		$6K Buy
+150
New +$5.85K ﹤0.01% 187

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Quantum Capital Management (California)'s TEVA Position: Q3 2020 in Review

Quantum Capital Management (California) held its Teva Pharmaceuticals (TEVA) position steady in Q3 2020 at 50 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #282.

Quantum Capital Management (California) first reported a position in TEVA in Q3 2013 and has held it in 6 quarters since. The position peaked at $6K in Q3 2013. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Quantum Capital Management (California) held 50 shares of Teva Pharmaceuticals worth $0 as of Q3 2020.
  • Quantum Capital Management (California) left its Teva Pharmaceuticals share count unchanged in Q3 2020.
  • Teva Pharmaceuticals made up ﹤0.01% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #282 holding.
  • Quantum Capital Management (California) first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 6 quarters since.
  • Quantum Capital Management (California)'s Teva Pharmaceuticals position peaked at $6K in Q3 2013.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.